- Trials with a EudraCT protocol (18)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
18 result(s) found for: Right Atrium.
Displaying page 1 of 1.
EudraCT Number: 2021-000442-18 | Sponsor Protocol Number: ABM/2020/1/00002 | Start Date*: 2021-09-24 | ||||||||||||||||
Sponsor Name:National Institute of Cardiology | ||||||||||||||||||
Full Title: Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial) | ||||||||||||||||||
Medical condition: Mitral regurgitation Atrial fibrilation Periprocedural anticoagulation strategy in patients treated with MitraClip implantation or Left Atrial Appendage Closure. The patients scheduled for Mitr... | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000420-38 | Sponsor Protocol Number: 2021-01755 | Start Date*: 2023-09-18 |
Sponsor Name:Universitätsmedizin Göttingen | ||
Full Title: Dapagliflozin in patients with Right Heart Failure (Dapa-RHF) | ||
Medical condition: Right heart failure defined as (criteria a-c must all be fulfilled): a) Reduced right ventricular systolic function or RV strain defined as at least one of the following b) N-terminal pro-BNP (NT... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002257-19 | Sponsor Protocol Number: CARDIORYC-2014-001 | Start Date*: 2015-04-21 | |||||||||||
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Ramón y Cajal | |||||||||||||
Full Title: Single-center, randomized, open, controlled by echocardiography to evaluate the effect of serelaxina in the functioning of the right ventricle and its potential in the prognosis of acute heart fail... | |||||||||||||
Medical condition: ICA hospitalized patients with high normal blood pressure, and mild to moderate renal failure at the time of selection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001657-28 | Sponsor Protocol Number: CTHC002 | Start Date*: 2014-01-23 | |||||||||||
Sponsor Name:University Medical Center of the Johannes Gutenberg University Mainz | |||||||||||||
Full Title: Home Treatment of Patients with Low-Risk Pulmonary Embolism with the Oral Factor Xa Inhibitor Rivaroxaban: Prospective Management Trial (HoT-PE) | |||||||||||||
Medical condition: Acute low-risk pulmonary embolism (PE) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PT (Completed) FI (Completed) ES (Completed) NL (Completed) GR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006334-33 | Sponsor Protocol Number: AJUAR | Start Date*: 2008-03-19 | |||||||||||||||||||||
Sponsor Name:Dr. Josep Brugada Terradellas- Hospital Clínic | |||||||||||||||||||||||
Full Title: Utilidad de la ajmalina intravenosa en el diagnóstico y tratamiento de las arritmias cardíacas | |||||||||||||||||||||||
Medical condition: Fibrilación auricular Taquicardia ventricular monomórfica sostenida Diagnóstico de Síndrome de Brugada | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: ES (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-003455-36 | Sponsor Protocol Number: D3190C00005 | Start Date*: 2007-12-21 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Multi-centre, Double-blind, Randomised, Placebo-controlled, Single-dose, Phase II Study to Assess the Effects on Atrial and Ventricular Refractoriness and Haemodynamics of an Intravenous Infusion... | ||
Medical condition: AZD1305 is a novel antiarrhythmic agent being developed for treatment of atrial fibrillation (AF). Potential indications include conversion of AF to sinus rhythm (SR) and maintenance of SR after c... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) SE (Prematurely Ended) DK (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2010-023839-42 | Sponsor Protocol Number: H8O-CY-O027 | Start Date*: 2011-04-29 | ||||||||||||||||
Sponsor Name:General University Hospital in Prague | ||||||||||||||||||
Full Title: EXEnatide in patients undergoing Coronary artery bypass grafting for improved glUcose conTrol and hemodynamIc ValuEs | ||||||||||||||||||
Medical condition: Patients with elective coronary artery bypass grafting with LV systolic dysfunction (EF LV ≤ 50%) | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: CZ (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-016077-14 | Sponsor Protocol Number: RALF1 | Start Date*: 2010-11-11 | |||||||||||
Sponsor Name:Mika Lehto | |||||||||||||
Full Title: Role of ALiskiren, a direct renin inhibitor, in preventing atrial Fibrillation in patients with a pacemaker; RALF Eteisvärinäkuorman määritys sydämentahdistimella aliskireenihoidossa | |||||||||||||
Medical condition: Patients who have a pacemaker due to sinus node disease and paroxysmal atrial fibrillation. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FI (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005310-19 | Sponsor Protocol Number: PI-0697-2012 | Start Date*: 2013-06-05 |
Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN BIOSANITARIA DE ANDALUCIA ORIENTAL_ FPA | ||
Full Title: Double-blind randomized clinical trial to evaluate the efficacy and safety of levosimendan as preischemic myocardial conditioner in pediatric cardiac surgery | ||
Medical condition: Children aged 1 month to 14 years in the health area of the province of Granada who will be undergoing heart surgery with a clinical high risk of developing acute heart failure after surgery, treat... | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003883-30 | Sponsor Protocol Number: 044CF13273 | Start Date*: 2014-01-30 | |||||||||||
Sponsor Name:Aziende Chimiche Riunite Angelini Francesco ACRAF S.p.A | |||||||||||||
Full Title: Efficacy and safety of paracetamol in comparison to ibuprofen for patent ductus arteriosus treatment in preterm infants. A randomized, open label, comparator-controlled, prospective study. | |||||||||||||
Medical condition: Patent ductus arteriosus | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-002754-74 | Sponsor Protocol Number: 67896062PAH1013 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:ACTELION Pharmacteuticals Ltd. | |||||||||||||
Full Title: A multicenter, open-label, single-arm study to assess the pharmacokinetics and safety of macitentan in children aged 1 month to <2 years with pulmonary arterial hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) PL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011279-56 | Sponsor Protocol Number: IBU/20mg/2009 | Start Date*: 2009-07-31 | |||||||||||
Sponsor Name:Orphan Europe Recordati | |||||||||||||
Full Title: Multicenter open-label pilot study to evaluate the safety, pharmacology and efficacy of a new dose regimen (i.e. 20-10-10 mg/kg) of Pedea (intravenous ibuprofen) in preterm newborn infants of less ... | |||||||||||||
Medical condition: Hemodynamically significant persisting ductus arteriosus in preterm infants of less than 28 weeks of gestational age | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2023-000984-30 | Sponsor Protocol Number: 67896062PAH3001 | Start Date*: 2024-01-03 | |||||||||||
Sponsor Name:Janssen Pharmaceutical K.K. | |||||||||||||
Full Title: A Multicenter, Open-label, Phase III Study to Assess the Efficacy, Safety, and Pharmacokinetics of Macitentan in Japanese Pediatric Patients (≥3 months to <15 years) with Pulmonary Arterial Hyperte... | |||||||||||||
Medical condition: Pulmonary arterial hypertension | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-000110-19 | Sponsor Protocol Number: P060406 | Start Date*: 2012-01-10 | |||||||||||||||||||||
Sponsor Name:Assistance Publique – Hôpitaux de Paris (AP-HP) | |||||||||||||||||||||||
Full Title: Closure of patent foramen ovale or anticoagulants versus antiplatelet therapy to prevent stroke recurrence | |||||||||||||||||||||||
Medical condition: The study compares different strategies for secondary stroke (or retinal ischaemia) prevention in patients with patent foramen ovale. The three treatment arms comprise: 1. Endovascular patent f... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-004975-37 | Sponsor Protocol Number: LIMIT | Start Date*: 2021-09-06 |
Sponsor Name:Hamilton Health Sciences through the Population Health Research Institute | ||
Full Title: Low INR to Minimize bleeding with mechanical valves Trial | ||
Medical condition: Treatment with a Vitamin K Antagonist due to having a mechanical heart valve. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Ongoing) ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-005077-39 | Sponsor Protocol Number: BBLOQ-2017 | Start Date*: 2018-06-12 | |||||||||||
Sponsor Name:Instituto de Investigación Sanitaria INCLIVA | |||||||||||||
Full Title: Betablockers Withdrawal in Patients with Heart Failure with Preserved Ejection Fraction and Chronotropic Incompetence: Effect on Functional Capacity and life quality | |||||||||||||
Medical condition: Heart Failure | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-006290-25 | Sponsor Protocol Number: 4141 | Start Date*: 2012-05-03 |
Sponsor Name:Copenhagen University Hospital Rigshospitalet, The Heart Center - Department of Thoracic Surgery | ||
Full Title: The Pulmonary Protection Trial (PP-Trial) Pulmonary dysfunction after open heart surgery: Randomized clinical trial with focus on lung-protective interventions | ||
Medical condition: Dysfunction of the lungs after open heart surgery. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003543-30 | Sponsor Protocol Number: EORTC-1809-STBSG | Start Date*: 2020-12-16 | ||||||||||||||||
Sponsor Name:European Organisation for Research and Treatment of Cancer | ||||||||||||||||||
Full Title: A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with High Risk RetroPeritoneal Sarcoma | ||||||||||||||||||
Medical condition: Primary high risk leiomyosarcoma or Liposarcoma of retroperitoneal space or infra-peritoneal spaces of pelvis | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) SK (Trial now transitioned) PL (Trial now transitioned) CZ (Trial now transitioned) NL (Trial now transitioned) IT (Ongoing) DE (Trial now transitioned) CY (Trial now transitioned) DK (Trial now transitioned) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.